Risk and Safety of Probiotics
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
Probiotics have been used safely for years. Safety outcomes are inconsistently reported in published clinical trials. In 2011, a report released by the Agency for Healthcare Research and Quality concluded that, although the existing probiotic clinical trials reveal no evidence of increased risk, "the current literature is not well equipped to answer questions on the safety of probiotics in intervention studies with confidence." Critics point out that the preponderance of evidence, including the long history of safe probiotic use as well as data from clinical trials, and animal and in vitro studies all support the assumption that probiotics are generally safe for most populations. Theoretical risks have been described in case reports, clinical trial results and experimental models, include systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, gene transfer and gastrointestinal side effects. More research is needed to properly describe the incidence and severity of adverse events related to probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although probiotics are widely used and generally considered safe for healthy individuals, accumulating evidence indicates that their safety profile varies significantly depending on the strain, dose, host, and context, with rare but clinically significant adverse events reported in vulnerable populations.”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Vulnerable populations (newborns, immunocompromised individuals, and critically ill individuals) are at greater risk; therefore, assessing regulatory compliance requires a combination of biochemical and metabolomic studies, whole genome sequencing for virulence, antibiotic resistance genes and motility mapping [63,66,87].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in the same year, Doron et al. (2015) conducted an analysis based solely on traditional literature review methods based on the results of 622 probiotic safety studies [63].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with established guidance, probiotic safety is linked to intended use, strain identity, and historical evidence of safe exposure, and is distinct from classical pathogenic risk assessment.20-22”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of such ARGs and VFs may have clinical relevance, particularly in immunocompromised individuals or those with disrupted gut barriers, where opportunities for opportunistic infection or horizontal gene transfer may be increased.22,29-35”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measured
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., & Isolauri, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04259-8 · Cited by 2,432 · cited 1×
“Pregnant women [19–21] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii None”
BackgroundBesselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Probiotics in the management of atopic eczema
Isolauri, E., Arvola, T., SÜtas, Y., Moilanen, E., & Salminen, S. (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00943.x · Cited by 974 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics: A novel approach in the management of food allergy
Majamaa, H., & Isolauri, E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70093-9 · Cited by 918 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741
Lactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599 · cited 1×
“Nine cases of overt sepsis have been reported [57–63], asso-”
BackgroundKhalesi, S., Sun, J., Buys, N., & Jayasinghe, R. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03469 · Cited by 516
Rayes, N., Seehofer, D., Theruvath, T., Schiller, R. A., Langrehr, J. M., Jonas, S., Bengmark, S., & Neuhaus, P. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00649.x · Cited by 478 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
BackgroundRayes, N., Seehofer, D., Hansen, S., Boucsein, K., M??ller, A. R., Serke, S., Bengmark, S., & Neuhaus, P. (2002) · Transplantation · doi:10.1097/00007890-200207150-00021 · Cited by 476 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
Background
Research works printed but not linked: 3
- Kukkonen, 2008, Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial, Pediatrics, 122, 8, 10.1542/peds.2007-1192 · DOI · Paper page
- Trautmann, 2008, Fungemia due to Saccharomyces cerevisiae var. boulardii, Chemother J, 17, 57
- Lestin, 2003, Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities, Dtsch Med Wochenschr, 128, 2531
Cited by
Items 201–300 of 1,000
Arellano-García, L., Trepiana, J., Martínez, J. A., Portillo, M. P., & Milton‐Laskibar, I. (2023) · Antioxidants · doi:10.3390/antiox12030717 · Cited by 47
“According to the Food and Agriculture Organization/World Health Organization (FAO/WHO), probiotics may predispose some individuals to certain side effects such as systemic infections, deleterious metabolic activities, excessive immune stimulation, and gene transfer [15].”
BackgroundThe Development of Early Life Microbiota in Human Health and Disease
Lv, H., Zhang, L., Han, Y., Wu, L. M., & Wang, B. (2021) · Engineering · doi:10.1016/j.eng.2020.12.014 · Cited by 47
Carter, G. M., Esmaeili, A., Shah, H., Indyk, D., Johnson, M., Andreae, M., & Sacks, H. S. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw164 · Cited by 47
“Several case reports document probiotic organisms causing sepsis [16], but no studies provide numerical estimates of risk.”
BackgroundPostbiotics in inflammatory bowel disease: efficacy, mechanism, and therapeutic implications
Wang, S., Wang, P., Wang, D., Shen, S., Wang, S., Li, Y., & Chen, H. (2024) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.13721 · Cited by 47
Zhang, Z., Zhang, H., Yang, D., Hao, Q., Yang, H., Meng, D., de Vos, W. M., Guan, L. L., Liu, S., Teame, T., et al. (2024) · iMeta · doi:10.1002/imt2.181 · Cited by 47
“Probiotic application leads to systemic infections, deleterious metabolic activities and gastrointestinal side effects in these susceptible individuals [82].”
BackgroundAbbasi, A., Rad, A. H., Maleki, L. A., Kafil, H. S., & Baghbanzadeh, A. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-10039-1 · Cited by 47
The microbial revolution: Unveiling the benefits of vaginal probiotics and prebiotics
Pagar, R. R., Deshkar, S. S., Mahore, J., Patole, V., Deshpande, H. G., Gandham, N. R., MIRZA, S. B., Junnarkar, M. V., & Nawani, N. N. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127787 · Cited by 46
Han, Z., Zhang, C., An, J.-X., Qiao, J., & Zhang, X. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102093 · Cited by 46
Probiotics and prevention of Clostridium difficile infection
Goldstein, E. J. C., Johnson, S., Maziade, P.-J., Evans, C. T., Sniffen, J. C., Millette, M., & McFarland, L. V. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.12.007 · Cited by 46
Probiotic capability of novel lactic acid bacteria isolated from worker honey bees gut microbiota
El-Zeini, H., Ali, A. R. A. A., Nasr, N. F., Hassan, M., Hassan, A. A.-M., & Elenany, Y. E. (2021) · FEMS Microbiology Letters · doi:10.1093/femsle/fnab030 · Cited by 46
Priming with intranasal lactobacilli prevents Pseudomonas aeruginosa acute pneumonia in mice
Fangous, M.-S., Gosset, P., Galakhoff, N., Gouriou, S., Guilloux, C.-A., Payan, C., Vallet, S., Héry-Arnaud, G., & Berre, R. L. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02254-7 · Cited by 46
Flori, L., Benedetti, G., Martelli, A., & Calderone, V. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107334 · Cited by 45
Probiotics, Prebiotics, and Synbiotics: What Are They and How Do They Affect Obesity?
Jacobs, L. (2017) · Journal of Pediatric Surgical Nursing · doi:10.1097/jps.0000000000000140 · Cited by 45
“…Surgical Nursing Associatio exceptions to this rule would include critically ill and immune-compromised patients and those with indwelling central vein catheters or possibly cardiac valve disease as there have been a few case reports of systemic infections and endocarditis (Doron & Snydman, 2015).”
BackgroundJain, M., Stitt, G. A., Son, L., & Enioutina, E. Y. (2023) · Microorganisms · doi:10.3390/microorganisms11102393 · Cited by 45
“Some clinical data suggest that probiotics are effective as a monotherapy or adjunct for the treatment of infectious diseases [12].”
BackgroundInfluentialPanpetch, W., Sawaswong, V., Chanchaem, P., Ondee, T., Dang, C. P., Payungporn, S., Tumwasorn, S., & Leelahavanichkul, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613095 · Cited by 45
Bhoopathy, S., Inbakandan, D., Thirugnanasambandam, R., Kumar, C., Bhindhiya Prabha, S., Reddy, B. A., Kasilingam, R., RameshKumar, V., & Dharani, G. (2021) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2021.08.002 · Cited by 45
Accounting for the health risk of probiotics
Liu, X., Zhao, H., & Wong, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27908 · Cited by 44
Microbiota‐derived extracellular vesicles and metabolic syndrome
Villard, A., Boursier, J., & Andriantsitohaina, R. (2021) · Acta Physiologica · doi:10.1111/apha.13600 · Cited by 44
Kaufmann, B. K., Seyfried, N., Hartmann, D., & Hartmann, P. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00017.2023 · Cited by 44
Chakravarty, K., Gaur, S., Kumar, R., Jha, N. K., & Gupta, P. K. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10328-x · Cited by 44
“Some significant risks involved with probiotic usage as therapy or in diet could be systemic infection development, disruption in metabolism and toxin secretion by some contaminant microbe, or misidentified probiotics in a composite culture [214].”
Cheng, B., Zeng, X., Liu, S., Zou, J., & Wang, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-78281-7 · Cited by 43
Acid-Suppressive Therapy and Risk of Infections: Pros and Cons
Fisher, L., & Fisher, A. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0519-y · Cited by 43
Bacterial extracellular vesicles: emerging mediators of gut-liver axis crosstalk in hepatic diseases
Zhou, Y., Sun, Y., Yin, P., Zuo, S., Li, H., & Cao, K. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1620829 · Cited by 43
Pantazi, A. C., Kassim, M. A. K., Nori, W., Tuta, L. A., Mihai, C. M., Chisnoiu, T., Bălașa, A. L., Mihai, L., Lupu, A., Frecuș, C. E., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11092480 · Cited by 42
Dysbiosis of human microbiome and infectious diseases
Gupta, A., Singh, V., & Mani, I. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.016 · Cited by 42
Wombwell, E., Patterson, M. E., Bransteitter, B. A., & Gillen, L. R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa808 · Cited by 42
Dealing with the remaining controversies of probiotic safety
van den Nieuwboer, M., & Claassen, E. (2019) · Beneficial Microbes · doi:10.3920/bm2018.0159 · Cited by 42
Fu, S., Yang, Q., He, F., Lan, R., Hao, J., Ni, P., Liu, Y., & Li, R. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz642 · Cited by 42
Safety assessment of Lactobacillus reuteri IDCC 3701 based on phenotypic and genomic analysis
Lee, B. S., Ban, O., Bang, W. Y., Chae, S. A., Oh, S., Park, C., Lee, M., Kim, S.-J., Yang, J., & Jung, Y. H. (2021) · Annals of Microbiology · doi:10.1186/s13213-021-01622-y · Cited by 42
“Although these probiotics are prevalent in the intestine as beneficial microorganisms, they can cause adverse events such as inflammatory bowel disease in rare case (Doron and Snydman 2015).”
BackgroundLactobacillus reuteri DSM 17938 Improves Feeding Intolerance in Preterm Infants
Kaban, R. K., Wardhana, Hegar, B., Rohsiswatmo, R., Handryastuti, S., Amelia, N., Muktiarti, D., Indrio, F., & Vandenplas, Y. (2019) · Pediatric Gastroenterology Hepatology & Nutrition · doi:10.5223/pghn.2019.22.6.545 · Cited by 42
“Cases were reported of sepsis due to Lactobacillus including L. acidophilus , L. casei , L. GG , S. boulardii , Bacillus subtilis , and Bifidobacterium breve [19,20].”
Safety of probiotics used for hospital environmental sanitation
Caselli, E., Antonioli, P., & Mazzacane, S. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.06.021 · Cited by 41
Carolak, E., Czajkowska, J., Stypułkowska, A., Waszczuk, W., Dutkiewicz, A., & Grzymajło, K. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2519696 · Cited by 41
Arellano-García, L., Portillo, M. P., Martínez, J. A., & Milton‐Laskibar, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063167 · Cited by 41
“Despite the aforementioned probiotic health benefits, their administration also involves some hazards, since this therapeutic approach is based on the administration of life/viable microorganisms to vulnerable subjects, which in turn results in an increased risk of systemic infection and/or immune system overstimulati…”
BackgroundEfficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis
Jia, L.-Q., Sun, J.-R., Kong, C.-F., Qu, X.-K., Deng, C., & Lou, Y.-N. (2020) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_384_19 · Cited by 40
“However, safety outcomes are inconsistently reported in published clinical trials.[54] In the current study, we assessed the efficacy and safety of probiotics in IBS, and we detected the effect of different strains and species of probiotics by subgroup analysis.”
BackgroundGut microbiota manipulation as an epilepsy treatment
Iannone, L. F., Gómez-Eguílaz, M., & Caro, C. D. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105897 · Cited by 40
“These risks include sepsis, localized infections, metabolic disturbance, excessive immune activations as well as gastrointestinal adverse effects (Doron and Snydman, 2015).”
Mayer, S., BONHAG, C. M., Jenkins, P., Cornett, B., Watts, P. J., & Scherbak, D. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000005953 · Cited by 40
“The U.S. Food and Drug Administration lists immunosuppression as a risk factor for an adverse event with probiotic administration (29, 31, 32).”
Assessment of the Safety of Lactobacillus casei IMV B-7280 Probiotic Strain on a Mouse Model
Lazarenko, L. M., Babenko, L. P., Gichka, S. G., Sakhno, L. O., Demchenko, O. M., Bubnov, R. V., Sichel, L. M., & M.Ya., S. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09789-1 · Cited by 40
Cuomo, A., Maina, G., Rosso, G., Crescenzi, B. B., Bolognesi, S., Muro, A. D., Giordano, N. G., Goracci, A., Neal, S. M., Nitti, M. P., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01040 · Cited by 40
“However, other studies have produced controversial results and therefore more trials are needed to completely demonstrate efficacy, to identify the specific strains that are most beneficial, as well as the correct dose and treatment duration (Doron and Snydman, 2015; Bruce-Keller et al., 2018).”
ResultGut Microbiota for Esophageal Cancer: Role in Carcinogenesis and Clinical Implications
Zhou, J., Sun, S., Luan, S., Xiao, X., Yang, Y., Mao, C., Chen, L., Zeng, X., Zhang, Y., & Yuan, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.717242 · Cited by 39
“Administration of Probiotics Probiotics are live microbes that benefit health by improving the gut microbiota after being administered (91).”
BackgroundProbiotics and Prebiotics as a Strategy for Non-Alcoholic Fatty Liver Disease, a Narrative Review
Castillo, V., Figueroa, F., González-Pizarro, K., Jopia, P., & Ibacache‐Quiroga, C. (2021) · Foods · doi:10.3390/foods10081719 · Cited by 39
Antibiotics and probiotics in inflammatory bowel disease: when to use them?
Abraham, B., & Quigley, E. M. M. (2020) · Frontline Gastroenterology · doi:10.1136/flgastro-2018-101057 · Cited by 39
“62 63 Since probiotic strains typically do not colonise the adult colon and repeated or indefinite use is required for an ongoing effect, long-term maintenance studies in IBD are needed.”
The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics
Guo, X., Yang, X., Li, Q., Shen, X., Zhong, H., & Yang, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.759095 · Cited by 39
“Its main clinical features are multiple systems and organs involvement, repeated relapse and remission, and the development of a large pool of autoantibodies against double-stranded (ds) DNA (Lisnevskaia et al., 2014; Durcan et al., 2019; Fava and Petri, 2019).”
BackgroundAlatawi, H. A., Mosli, M. H., Saadah, O. I., Annese, V., Al-Hindi, R. R., Alatawy, M., Al-Amrah, H., Alshehri, D., Bahieldin, A., & Edris, S. (2022) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2021.6436 · Cited by 39
“Consequently, this phenomenon may be linked with a number of diseases, such as bacterial infections and sepsis [30].”
BackgroundConjugal Transfer of Antibiotic Resistances in Lactobacillus spp.
Ojha, A. K., Shah, N. P., & Mishra, V. (2021) · Current Microbiology · doi:10.1007/s00284-021-02554-1 · Cited by 39
Rahimi, A., Qaisar, S. A., Janeh, T., Karimpour, H., Darbandi, M., & Moludi, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-76153-y · Cited by 38
“Conversely, research indicates that probiotics should be avoided in immunosuppressed patients or those with severe acute pancreatitis 33 ; however, such side effects are not observed with postbiotic supplementation.”
BackgroundTélessy, I. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813148-0.00024-4 · Cited by 38
Dinić, M., Burgess, J. L., Lukić, J., Catanuto, P., Radojević, D., Marjanović, J., Verpile, R., Thaller, S. R., Gonzalez, T., Golić, N., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202400054rr · Cited by 38
Co‐Encapsulation of Probiotics and Prebiotics: Techniques and Applications in Food Fortification
Shanuke, D. S., Ranasinghage, N. B. D. P., Illippangama, A. U., Kulathunga, J., & Bandara, M. D. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70426 · Cited by 38
“The microorganisms such as Bifidobacterium spp., Lactobacillus spp., and Enterococcus spp., and some yeasts such as Saccharomyces spp., are mostly known as probiotics for their health-promoting activities, besides their uses in food science (Doron and Snydman 2015).”
Lugli, G. A., Mangifesta, M., Mancabelli, L., Milani, C., Turroni, F., Viappiani, A., van Sinderen, D., & Ventura, M. (2019) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2019.01.011 · Cited by 37
Live biotherapeutic products and their regulatory framework in Italy and Europe.
Franciosa, G., Guida, S., Gomez, M. J., & von Hunolstein, C. (2023) · Annali dell Istituto Superiore di Sanità · doi:10.4415/ann_23_01_09 · Cited by 37
Can Probiotics Emerge as Effective Therapeutic Agents in Apical Periodontitis? A Review
Kumar, G., Tewari, S., Tagg, J. R., Chikindas, M. L., Popov, I. V., & Tiwari, S. K. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09750-2 · Cited by 37
Use of probiotics in prevention and treatment of patients with Clostridium difficile infection
Ollech, J. E., Shen, N. T., Crawford, C. V., & Ringel, Y. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.01.002 · Cited by 38
Gorbach, S. L., Doron, S., & Magro, F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00007-0 · Cited by 37
Self-citationDu, S., Jia, Y., Ren, S., Gong, X., Tang, H. W., Wu, W., & Sun, L.-M. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.09.005 · Cited by 37
Bacteremia after Bacillus clausii administration for the treatment of acute diarrhea: A case report
Henao, J. P. G., Hoyos-Pulgarín, J. A., Alzate, J. A., & Quintero, E. C. (2021) · Biomédica · doi:10.7705/biomedica.5662 · Cited by 37
“Anyway the World Health Organization has acknowledged probiotics might be responsible for systemic infections and deleterious metabolic activity (9).”
BackgroundAlvarez, A.-S., Tap, J., Chambaud, I., Cools-Portier, S., Quinquis, L., Bourlioux, P., Marteau, P., Guillemard, E., Schrezenmeir, J., & Derrien, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-72161-w · Cited by 36
Barroso, F. A. L., de Jesus, L. C. L., da Silva, T. F., Batista, V. L., Laguna, J. G., Coelho-Rocha, N. D., Vital, K. D., Fernandes, S. O. A., Cardoso, V. N., Ferreira, E. F., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.858036 · Cited by 36
Probiotics and muscle health: the impact of Lactobacillus on sarcopenia through the gut-muscle axis
Zhu, J., Peng, F., Yang, H., Luo, J., Zhang, L., Chen, X., Liao, H., Lei, H., Liu, S., Yang, T., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1559119 · Cited by 36
“This involves the migration of bacteria from the gut to other parts of the body, such as the bloodstream or internal organs, potentially leading to infections and even rare cases of systemic infections including bacteremia, have occurred (Doron and Snydman, 2015; Sanders et al., 2016).”
Consenso mexicano sobre probióticos en gastroenterología
Valdovinos, M. A., Montijo, E., y Abreu, A. T. A., Heller, S., Garay, A. G. G., Nogales, D. B., Bielsa-Fernández, M. V., Bojórquez-Ramos, M. D. C., Bosques‐Padilla, F., Burguete-García, A. I., et al. (2017) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2016.08.004 · Cited by 38
Bacterial extracellular vesicles in the initiation, progression and treatment of atherosclerosis
Lin, Y., Wang, J., Bu, F., Zhang, R., Wang, J., Wang, Y., Huang, M., Huang, Y., Zheng, L., Wang, Q., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2452229 · Cited by 36
Phan, A., Mijar, S., Harvey, C. M., & Biswas, D. (2025) · Microorganisms · doi:10.3390/microorganisms13081732 · Cited by 35
“As they are live microorganisms, caution must be taken in those with underlying health conditions, such as immunodeficiency, acute abdominal or intestinal infection, or heart disease, to prevent potential infection [296].”
Tian, R., Liu, H., Feng, S., Wang, H., Wang, Y., Wang, Y., Liang, L., Xu, H., Xing, H., & Zhang, S. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.01.007 · Cited by 35
Falzone, L., Lavoro, A., Candido, S., Salmeri, M., Zanghì, A., & Libra, M. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2397874 · Cited by 35
“130,131 In this field, regulatory requirements for probiotic safety may vary depending on the country and it is difficult to provide globally accepted guidelines (Figure 2).”
BackgroundProbiotics for Aquaculture: Hope, Truth, and Reality
Todorov, S. D., Lima, J. M. S., Bucheli, J. E. V., Popov, I. V., Tiwari, S. K., & Chikindas, M. L. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10290-8 · Cited by 35
“Probiotics should be screened for the absence of antibiotic resistance or virulence genes on the mobile genetic elements before applying them in aquaculture [47].”
The Intestinal Effect of Atorvastatin: Akkermansia muciniphila and Barrier Function
Cheng, T., Li, C., Shen, L., Wang, S., Li, X., Fu, C., Li, T., Liu, B., Gu, Y., Wang, W., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.797062 · Cited by 35
Manirarora, J. N., Kosiewicz, M. M., & Alard, P. (2020) · Autoimmunity · doi:10.1080/08916934.2020.1777282 · Cited by 35
Zielińska, D., Sionek, B., & Kołożyn-Krajewska, D. (2018) · Diet, Microbiome and Health · doi:10.1016/b978-0-12-811440-7.00006-5 · Cited by 34
Gut–lung axis: role of the gut microbiota in non-small cell lung cancer immunotherapy
Zhang, H., & Xu, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1257515 · Cited by 34
“On the other hand, critics argue that the overwhelming body of evidence, including a long history of safe probiotic usage and data from clinical trials, alongside animal and in vitro research, supports the understanding that probiotics are generally safe for most individuals (118).”
BackgroundExploring the future of probiotics with innovations in delivery systems and market insights
Ramírez, A., Bermúdez-Luque, A., Román‐Camacho, J. J., Martín-García, F. J., Moreno‐García, J., Güngörmüşler, M., & Ruiz-Castilla, F. J. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107029 · Cited by 34
Yang, N., Ma, T., Xie, Y., Li, Q., Li, Y., Zheng, L., Li, Y., Xiao, Q., Sun, Z., Zuo, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51094-2 · Cited by 34
“Adverse events, including systemic infection, deleterious metabolic activities, excessive immune stimulation, and gastrointestinal side effects 89 , were recorded throughout the intervention period.”
Dao, H. V., Hoang, L. B., Trinh, T. O., Tran, T. T. T., & Dao, L. V. (2021) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s312316 · Cited by 34
Kulig, K., Kowalik, K., Surowiec, M., Karnas, E., Woźnicka, O., Zuba‐Surma, E. K., Pyza, E., Kozik, A., Rąpała‐Kozik, M., & Karkowska‐Kuleta, J. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10085-3 · Cited by 34
“At the same time, the use of EVs instead of whole cell microorganisms avoids the potential risk of infection caused by the probiotic, which is not common, although some cases were reported [36, 37].”
Wan, Y., Zhu, R., Bian, Z.-Z., & Sun, T. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i2.224 · Cited by 34
Mohammadi, H., Ghavami, A., Faghihimani, Z., Sharifi, S., Nattagh‐Eshtivani, E., Ziaei, R., & Miraghajani, M. S. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104494 · Cited by 34
The Crucial Roles of Diet, Microbiota, and Postbiotics in Colorectal Cancer
Kuru-Yaşar, R., & Üstün‐Aytekin, Ö. (2024) · Current Nutrition Reports · doi:10.1007/s13668-024-00525-z · Cited by 33
“It is suggested that post-biotics are more advantageous than probiotics due to their stability in industrial processes and storage, long shelf life, not requiring a cold chain, more reliable profile in terms of health, and not having the risk of developing antibiotic resistance [14, 16, 69, 92–98].”
BackgroundZhang, Y., Pu, F., Cheng, R., Jiawen, G. U. O., Shen, X. P., Wang, S., Zhu, H., Zhang, X., Cheng, G., Li, M., et al. (2020) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2019-025 · Cited by 33
Appraisal of postbiotics in cancer therapy
Sudaarsan, A. S. K., & Ghosh, A. R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1436021 · Cited by 33
A Review of the Use of Native and Engineered Probiotics for Colorectal Cancer Therapy
Han, H., Zhang, Y., Tang, H., Zhou, T., & Khan, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073896 · Cited by 33
Engineered probiotics: a new era in treating inflammatory bowel disease
Duan, S., Wang, Y., Zhan, S., Ye, Z., Luo, T., Zhou, Y., Xu, H., & Huang, H. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07271-y · Cited by 33
“This raises ethical debate about informed consent and the balance of risks and benefits [99, 100].”
Li, B., Pan, L., & Sun, J. T. (2022) · Antioxidants · doi:10.3390/antiox11071246 · Cited by 33
Saeed, M., Khanam, R., Hafeez, H., Ahmad, Z., Shahzad, S., Tariq, M. R., Safdar, W., Waseem, M., Ali, U., Azam, M., et al. (2024) · ACS Omega · doi:10.1021/acsomega.3c08588 · Cited by 33
Sultana, O. F., Hia, R. A., & Reddy, P. H. (2024) · Antioxidants · doi:10.3390/antiox13020202 · Cited by 32
Role of bile acids in overweight and obese children and adolescents
Giannini, C., Mastromauro, C., Scapaticci, S., Gentile, C., & Chiarelli, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1011994 · Cited by 32
A Review of Next-Generation Probiotics—As a Gateway to Biotherapeutics
Vijayaganapathi, A., & Mohanasrinivasan, V. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10606-2 · Cited by 32
Sahoo, D., Rodriguez, E., Nguyen, K. T., & Chintapula, U. K. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00959 · Cited by 32
Valdovinos-García, L. R., y Abreu, A. T. A., & Valdovinos-Díaz, M. Á. (2018) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2018.10.001 · Cited by 32
“Even though the literature contains reports of a very limited number of cases of bacteremia due to Lactobacilli, and fungemia due to yeasts, in patients with central vein catheters or that are immunosuppressed, in general, probiotics are recognized to be a safe therapeutic tool, with no major adverse events.(26) One o…”
BackgroundLimosilactobacillus reuteri Strains as Adjuvants in the Management of Helicobacter pylori Infection
Dargenio, C., Dargenio, V. N., Bizzoco, F., Indrio, F., Francavilla, R., & Cristofori, F. (2021) · Medicina · doi:10.3390/medicina57070733 · Cited by 32
Juhász, J., Ligeti, B., Gajdács, M., Makra, N., Ostorházi, E., Farkas, F. B., Stercz, B., Tóth, Á., Domokos, J., Pongor, S., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10030268 · Cited by 32
Probiotics from the standpoint of evidence-based medicine
Кайбышева, В. О., & Nikonov, E. L. (2019) · Russian Journal of Evidence-Based Gastroenterology · doi:10.17116/dokgastro2019803145 · Cited by 32
Current Concepts in Probiotic Safety and Efficacy
Churin, A. A., Sokolyanskaya, L. O., Lukina, A. P., & Karnachuk, O. V. (2026) · Nutrients · doi:10.3390/nu18040696 · Cited by 31
“However, in the same year, Doron et al. (2015) conducted an analysis based solely on traditional literature review methods based on the results of 622 probiotic safety studies [63].”
Optimization of nutrition support practices early after hematopoietic cell transplantation
McMillen, K. K., Dickson, T. C., & Adintori, P. A. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-020-01078-9 · Cited by 31
Xu, R., Yu, Y., & Chen, T. (2025) · Current Research in Food Science · doi:10.1016/j.crfs.2025.101044 · Cited by 31
“…by diseases such as short gut syndrome (De Groote et al., 2005; Kunz et al., 2004), gastrointestinal bleeding (Zou et al., 2024), acute abdomen, perforated gastrointestinal tract, rupture in appendicitis, fistula of intestine and intestinal vessel (Doron and Snydman, 2015; Sadanand et al., 2019).”
Wawryk‐Gawda, E., Markut–Miotła, E., & Emeryk, A. (2021) · Allergologia et Immunopathologia · doi:10.15586/aei.v49i4.69 · Cited by 31
The interplay between probiotics and host autophagy: mechanisms of action and emerging insights
Sadeghloo, Z., Nabavi-Rad, A., Zali, M. R., Klionsky, D. J., & Yadegar, A. (2024) · Autophagy · doi:10.1080/15548627.2024.2403277 · Cited by 31
“Non-living microorganisms and their by-products are referred to as “postbiotics” [66,67].”
NETosis in ischemic/reperfusion injuries: An organ-based review
Hashemi, P., Nouri‐Vaskeh, M., Alizadeh, L., Baghbanzadeh, A., Badalzadeh, R., Askari, E., & Baradaran, B. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120158 · Cited by 31
Samtiya, M., Bhat, M. I., Gupta, T., Kapila, S., & Kapila, R. (2019) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-019-09529-6 · Cited by 31
“Safety outcomes of probiotics are inconsistently reported in clinical trials, and their associated adverse events have been recently reviewed byDoron and Snydmanseen [5].”
BackgroundEnterococcus faecium Regulates Honey Bee Developmental Genes
Du, Y., Luo, S., & Zhou, X. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212105 · Cited by 31
Halophilic lactic acid bacteria — Play a vital role in the fermented food industry
Nguyen, P.-T., Nguyen-Thi, T.-U., Nguyen, H., Pham, M.-N., & Nguyen, T. M. N. (2024) · Folia Microbiologica · doi:10.1007/s12223-024-01149-0 · Cited by 31
“However, because there are numerous studies showing that probiotics at very high doses are extremely safe, these are not meaningful risks for the vast majority of people (Doron and Snydman 2015).”
Evaluation of Probiotics for Warfighter Health and Performance
Agans, R., Giles, G. E., Goodson, M. S., Karl, J. P., Leyh, S. M., Mumy, K. L., Racicot, K., & Soares, J. W. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.00070 · Cited by 30
Venturini, L., Bacchi, S., Capelli, E., Lorusso, L., Ricevuti, G., & Cusa, C. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/1684198 · Cited by 30
“Finally, although probiotics are considered safe, there are concerns about their use in people with highly compromised immune systems, and in premature infants, as revealed by some infection events as a consequence of probiotic intake in immunosuppressed children and in severely debilitated patients [52, 77, 78].”
Background
Metadata
- Authors
- Doron, S., & Snydman, D. R.
- Affiliations
- Tufts Medical Center (US)
- Corresponding author
- Doron, Shira
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-28
- Volume
- 60
- Issue
- suppl_2
- Pages
- S129-S134
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC4490230
- OpenAlex
- W2027617880
- Cited by
- 942
- References
- 91
- Citations by year
- 2026: 89 · 2025: 105 · 2024: 112 · 2023: 105 · 2022: 99 · 2021: 100 · 2020: 135 · 2019: 85 · 2018: 55 · 2017: 32 · 2016: 18 · 2015: 7
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k23at003391-03)
- National Center for Complementary and Integrative Health (K23 AT-003391, 5K23 AT003391-03)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, probiotic safety, adverse events, systemic infection, immunostimulation, gene transfer, gastrointestinal adverse effects, risk assessment
- MeSH terms
- Clinical Trials as Topic, Humans, Lactobacillus, Risk, Saccharomyces, United States, Fungemia, Sepsis, Probiotics, Gene Transfer, Horizontal, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.